症状性肌瘤子宫动脉栓塞术后并发症的危险因素:一项病例对照研究

IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Bjog-An International Journal of Obstetrics and Gynaecology Pub Date : 2024-12-01 DOI:10.1111/1471-0528.18023
Adeline de Wit, Marc-Florent Tassi, Denis Herbreteau, Henri Marret
{"title":"症状性肌瘤子宫动脉栓塞术后并发症的危险因素:一项病例对照研究","authors":"Adeline de Wit,&nbsp;Marc-Florent Tassi,&nbsp;Denis Herbreteau,&nbsp;Henri Marret","doi":"10.1111/1471-0528.18023","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>We aim to clarify potential risk factors of complications after uterine artery embolisation (UAE).</p>\n </section>\n \n <section>\n \n <h3> Setting</h3>\n \n <p>Complications after uterine artery embolisation (UAE) for symptomatic fibroids are rare, but failure of treatment occurs for approximately 13%–24% of patients at 10 years.</p>\n </section>\n \n <section>\n \n <h3> Design</h3>\n \n <p>We conducted a case–control study including all complications post UAE over 15 years in our specialised unit.</p>\n </section>\n \n <section>\n \n <h3> Population</h3>\n \n <p>All Grade 2 complications (or worse) for the Society of Interventional Radiology Standards of Practice Committee complications post UAE were considered. One thousand one hundred seventy-two UAE were performed.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Complications were divided into two groups: early (&lt; 1 month) or late (≥ 1 month) to differentiate complications from failure of procedure. Multinomial analysis was conducted to assess links between complications and potential risk factors.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Sixty-nine (0.06%) complications were found: 24.6% hospitalisation for pain (<i>n</i> = 17/69), 30.4% for infection (<i>n</i> = 21/69) and 2.9% expulsion of fibroid (<i>n</i> = 2/69). Overall, 31 patients underwent a second procedure (45%).</p>\n </section>\n \n <section>\n \n <h3> Main Outcome Measures</h3>\n \n <p>Intra-uterine device and multiple fibroids were strongly related to early complications (OR<sub>early</sub> = 4.44, IC 95%: 1.5–13.3 and OR<sub>early</sub> = 3.7, IC 95%: 1.2–11.3, respectively). The only factor that appeared to be associated with risk of early and late complications was the major fibroid's diameter (for an increased size of 25 mm, OR<sub>early</sub> = 1.7, IC 95%: 1.1–2.6; OR<sub>late</sub> = 1.5, IC 95%: 1.04–2.2).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our study enlightens about the potential risk factors of UAE's complications and differentiate their impact between early and late complications.</p>\n </section>\n </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 4","pages":"518-528"},"PeriodicalIF":4.7000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18023","citationCount":"0","resultStr":"{\"title\":\"Risk Factors of Complications After Uterine Artery Embolisation for Symptomatic Fibroids: A Case–Control Study\",\"authors\":\"Adeline de Wit,&nbsp;Marc-Florent Tassi,&nbsp;Denis Herbreteau,&nbsp;Henri Marret\",\"doi\":\"10.1111/1471-0528.18023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>We aim to clarify potential risk factors of complications after uterine artery embolisation (UAE).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Setting</h3>\\n \\n <p>Complications after uterine artery embolisation (UAE) for symptomatic fibroids are rare, but failure of treatment occurs for approximately 13%–24% of patients at 10 years.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Design</h3>\\n \\n <p>We conducted a case–control study including all complications post UAE over 15 years in our specialised unit.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Population</h3>\\n \\n <p>All Grade 2 complications (or worse) for the Society of Interventional Radiology Standards of Practice Committee complications post UAE were considered. One thousand one hundred seventy-two UAE were performed.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Complications were divided into two groups: early (&lt; 1 month) or late (≥ 1 month) to differentiate complications from failure of procedure. Multinomial analysis was conducted to assess links between complications and potential risk factors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Sixty-nine (0.06%) complications were found: 24.6% hospitalisation for pain (<i>n</i> = 17/69), 30.4% for infection (<i>n</i> = 21/69) and 2.9% expulsion of fibroid (<i>n</i> = 2/69). Overall, 31 patients underwent a second procedure (45%).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Main Outcome Measures</h3>\\n \\n <p>Intra-uterine device and multiple fibroids were strongly related to early complications (OR<sub>early</sub> = 4.44, IC 95%: 1.5–13.3 and OR<sub>early</sub> = 3.7, IC 95%: 1.2–11.3, respectively). The only factor that appeared to be associated with risk of early and late complications was the major fibroid's diameter (for an increased size of 25 mm, OR<sub>early</sub> = 1.7, IC 95%: 1.1–2.6; OR<sub>late</sub> = 1.5, IC 95%: 1.04–2.2).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our study enlightens about the potential risk factors of UAE's complications and differentiate their impact between early and late complications.</p>\\n </section>\\n </div>\",\"PeriodicalId\":50729,\"journal\":{\"name\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"volume\":\"132 4\",\"pages\":\"518-528\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.18023\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bjog-An International Journal of Obstetrics and Gynaecology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.18023\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bjog-An International Journal of Obstetrics and Gynaecology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1471-0528.18023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

我们的目的是澄清子宫动脉栓塞(UAE)后并发症的潜在危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Risk Factors of Complications After Uterine Artery Embolisation for Symptomatic Fibroids: A Case–Control Study

Objective

We aim to clarify potential risk factors of complications after uterine artery embolisation (UAE).

Setting

Complications after uterine artery embolisation (UAE) for symptomatic fibroids are rare, but failure of treatment occurs for approximately 13%–24% of patients at 10 years.

Design

We conducted a case–control study including all complications post UAE over 15 years in our specialised unit.

Population

All Grade 2 complications (or worse) for the Society of Interventional Radiology Standards of Practice Committee complications post UAE were considered. One thousand one hundred seventy-two UAE were performed.

Methods

Complications were divided into two groups: early (< 1 month) or late (≥ 1 month) to differentiate complications from failure of procedure. Multinomial analysis was conducted to assess links between complications and potential risk factors.

Results

Sixty-nine (0.06%) complications were found: 24.6% hospitalisation for pain (n = 17/69), 30.4% for infection (n = 21/69) and 2.9% expulsion of fibroid (n = 2/69). Overall, 31 patients underwent a second procedure (45%).

Main Outcome Measures

Intra-uterine device and multiple fibroids were strongly related to early complications (ORearly = 4.44, IC 95%: 1.5–13.3 and ORearly = 3.7, IC 95%: 1.2–11.3, respectively). The only factor that appeared to be associated with risk of early and late complications was the major fibroid's diameter (for an increased size of 25 mm, ORearly = 1.7, IC 95%: 1.1–2.6; ORlate = 1.5, IC 95%: 1.04–2.2).

Conclusion

Our study enlightens about the potential risk factors of UAE's complications and differentiate their impact between early and late complications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.90
自引率
5.20%
发文量
345
审稿时长
3-6 weeks
期刊介绍: BJOG is an editorially independent publication owned by the Royal College of Obstetricians and Gynaecologists (RCOG). The Journal publishes original, peer-reviewed work in all areas of obstetrics and gynaecology, including contraception, urogynaecology, fertility, oncology and clinical practice. Its aim is to publish the highest quality medical research in women''s health, worldwide.
期刊最新文献
Correction to "The Hayman Technique: A Simple Method to Treat Postpartum Haemorrhage". Feasibility of a Standardised Mid-Trimester Ultrasound Protocol: A National Multicenter Study. Regarding the Association Between Polycystic Ovary Syndrome and Risk of Pre-Eclampsia. Issue Information Evaluating the Effectiveness of Assisted Oocyte Activation in ICSI: Pairwise Meta-Analyses and Systematic Evidence Evaluation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1